| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |